poisar

Stocks · News reference

Paxman Secures First UK Orders for Neuropathy System

Fiscal.ai

Paxman AB has received its first UK orders for its new Neuropathy System, marking the early stages of commercialization for the technology designed to address chemotherapy-induced peripheral neuropathy.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncNa

    Patria Reports Third Quarter 2026 Earnings Results

    Patria Investments Limited (Nasdaq: PAX) reported Q3 2026 results showing strong performance with $2.4 billion raised in the quarter and $6.9 billion year-to-date, reaching full-year fundraising targets ahead of schedule. The company generated Fee Related Earnings of $52.8 million (up 7% YoY) with a 53.7% FRE margin, and declared a quarterly dividend of $0.1625 per share. With over 85% of Fee-Earning AuM at or above benchmarks and $4.8 billion in pending Fee-Earning AuM, management expressed confidence in 2026 guidance and 2027 targets.